Allogene Therapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/3/2026 | 188 | 0.0% | 138,900 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 172 | 0.0% | 138,900 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 157 | 0.0% | 138,900 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 386 | 0.0% | 264,065 | 3/31/2025 |
| 2024 Q4 | 2/12/2025 | 548 | 0.0% | 253,576 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 663 | 0.0% | 236,696 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 573 | 0.0% | 245,934 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 972 | 0.0% | 217,495 | 3/31/2024 |
| 2023 Q4 | 2/8/2024 | 736 | 0.0% | 221,094 | 12/31/2023 |
| 2023 Q3 | 11/7/2023 | 583 | 0.0% | 183,963 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 914 | 0.0% | 183,963 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 817 | 0.0% | 165,378 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 941 | 0.0% | 163,445 | 12/31/2022 |
| 2022 Q3 | 11/1/2022 | 1,860 | 0.0% | 172,223 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 1,958 | 0.0% | 171,742 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 1,428 | 0.0% | 156,700 | 3/31/2022 |
| 2021 Q4 | 2/7/2022 | 2,367 | 0.0% | 154,826 | 12/31/2021 |
| 2021 Q3 | 11/4/2021 | 2,605 | 0.0% | 101,373 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 2,644 | 0.0% | 101,373 | 6/30/2021 |
| 2021 Q1 | 5/6/2021 | 2,107 | 0.0% | 59,685 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 1,411 | 0.0% | 55,900 | 12/31/2020 |
| 2020 Q3 | 11/10/2020 | 1,158 | 0.0% | 30,713 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 828 | 0.0% | 19,347 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 797 | 0.0% | 40,985 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 620 | 0.0% | 23,875 | 12/31/2019 |